Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 12;19(7):2031.
doi: 10.3390/ijms19072031.

New Insights in Anti-Angiogenesis in Multiple Myeloma

Affiliations
Review

New Insights in Anti-Angiogenesis in Multiple Myeloma

Domenico Ribatti et al. Int J Mol Sci. .

Abstract

Angiogenesis is a constant hallmark of multiple myeloma (MM) progression and involves direct production of angiogenic cytokines by plasma cells and their induction within the bone marrow microenvironment. This article summarizes the more recent literature data concerning the employment of anti-angiogenic therapeutic agents actually used in preclinical models and clinical settings for the treatment of multiple myeloma.

Keywords: angiogenesis; anti-angiogenesis; multiple myeloma; tumor growth.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Ribatti D., Nico B., Crivellato E., Roccaro A.M., Vacca A. The history of the angiogenic switch concept. Leukemia. 2007;21:44–52. doi: 10.1038/sj.leu.2404402. - DOI - PubMed
    1. Vacca A., Ribatti D., Roncali L., Ranieri G., Serio G., Silvestris F., Dammacco F. Bone marrow angiogenesis and progression in multiple myeloma. Br. J. Haematol. 1994;87:503–508. doi: 10.1111/j.1365-2141.1994.tb08304.x. - DOI - PubMed
    1. Ribatti D. The discovery of endothelial progenitor cells. Leuk. Res. 2007;31:439–444. doi: 10.1016/j.leukres.2006.10.014. - DOI - PubMed
    1. Maniotis A.J., Folberg R., Hess A., Seftor E.A., Gardner L.M.G., Pe’er J., Trent J.M., Meltzer P.S., Hendrix M.J.C. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am. J. Pathol. 1999;155:739–752. doi: 10.1016/S0002-9440(10)65173-5. - DOI - PMC - PubMed
    1. Holash J. Vessel cooption regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 1999;284:1994–1998. doi: 10.1126/science.284.5422.1994. - DOI - PubMed

MeSH terms

Substances